TNDM

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TNDM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/28	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/28	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/28	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/27	06 : 09	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/27	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/27	06 : 05	Business Wire	Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/25	22 : 30	Business Wire	Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/21	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/21	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/21	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/21	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/21	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/02/14	06 : 05	Business Wire	Tandem Diabetes Care Announces Upcoming Conference Presentations	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/01/16	06 : 05	Business Wire	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025	NASDAQ:TNDM	Tandem Diabetes Care Inc
2025/01/07	23 : 00	Business Wire	Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/12/19	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/12/19	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/12/10	23 : 00	Business Wire	Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/12/10	23 : 00	Business Wire	La pompe à insuline Tandem t:slim X2 est désormais compatible avec la SGC Dexcom G7 au Canada	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/22	06 : 05	Business Wire	Tandem Diabetes Care Announces Upcoming Conference Presentations	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/20	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/09	07 : 31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/07	06 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/07	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNDM	Tandem Diabetes Care Inc
2024/11/07	06 : 05	Business Wire	Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance	NASDAQ:TNDM	Tandem Diabetes Care Inc